Hopfgarten, Paris – May 19, 2010 - AlliedPanels, a leading medical engineering and manufacturing service provider and biospace med, an emerging medical technology company based in Paris, entered into a partnership. biospace med, has chosen the Austrian-based medical diagnostic imaging specialist AlliedPanels to assist the company in manufacturing some parts of its EOS 2D|3D Ultra Low dose imaging system. EOS is a revolutionary musculoskeletal imaging modality, the world’s first ultra-low-dose 2D|3D imager for use in paediatrics and adults, allowing full-body imaging of patients in a weight-bearing position, enabling global assessment of balance and posture. The partnership will also cover engineering services.


Good opportunities for both companies

AlliedPanels and biospace med see this agreement as mutually beneficial, especially with regard to both company’s growth strategies. “I am convinced that the path-breaking technology of EOS system has a great market potential”, says AlliedPanels CEO Hansjörg Weisskopf.  

 “We are convinced that AlliedPanels, with all its expertise in manufacturing and engineering for medical diagnostic imaging systems, is the partner that can help us in our market penetration. Together with our other partners they will contribute to establish EOS as the new standard in Orthopaedic imaging”, says Didier Saint-Félix, COO, biospace med.


About AlliedPanels

AlliedPanels is a global engineering, manufacturing and service partner to healthcare OEMs, such as General Electric and Siemens. With more than 20,000 medical diagnostic imaging produced, AlliedPanels has vast experience and deep knowledge in supporting medtech companies realizing their products. AlliedPanels is an Austria-based company with a US-subsidiary in Madison, Wisconsin.


About biospace

biospace med has developed EOS ultra-low-dose 2D|3D, a new medical imaging modality that allows full-body 2D and 3D imaging of patients. EOS is a novel technique and a global solution for orthopedic imaging that is now available in Europe and North America. Based in Paris, the Company currently has approximately 40 employees, and has a subsidiary in Cambridge, Massachusetts, USA, as well as an office in Montreal (Canada). It is targeting a $2 billion orthopedic imaging marketplace. In Paris, the Company headquarters is located at 10, rue Mercoeur - 75011 Paris (France) (+33 (0)1 55 25 60 60). Learn more at: www.biospacemed.com